Ajinomoto Co., Inc.

2802

JP3119600009

Food Processing

Market Closed - Japan Exchange Other stock markets 02:30:00 2025-06-19 am EDT			5-day change	1st Jan Change
3,721.00 ^JPY	0.00%		+2.11%	+15.34%

Jun. 09	Ajinomoto Co., Inc., 2025 Earnings Call, May 08, 2025
Jun. 06	Nearly 20% of Japanese Firms Forecast Record Profits	MT

Somite Therapeutics, Inc. announced that it has received funding from a group of investors

Published on 05/12/2025 at 18:00

Somite Therapeutics, Inc. announced that it has received $47 million in a round of funding led by new investor Khosla Ventures, LLC on May 13, 2025. The transaction included participation from new investors SciFi VC, Chan Zuckerberg Initiative, LLC, Fusion Fund, Ajinomoto Co., Inc., Pitango Venture Capital, Harpoon Ventures Management, LLC and returning investor Techaviv Management Co., Ltd. and angel investors Martin Chavez,Fidji Simo.

Latest news about Ajinomoto Co., Inc.

Ajinomoto Co., Inc., 2025 Earnings Call, May 08, 2025	Jun. 09
Nearly 20% of Japanese Firms Forecast Record Profits	Jun. 06	MT
Ajinomoto (Malaysia) Posts Qtrly Revenue 149.8 Million RGT	May. 29	RE
Somite Therapeutics, Inc. announced that it has received $47 million in funding from a group of investors	May. 12	CI
Somite Therapeutics, Inc. announced that it has received funding from a group of investors	May. 12	CI
Ajinomoto Buys Back 9.8 Million Shares Under New Program	May. 12	MT
Japan's Nikkei ends at more than one-month high on optimism around trade talks	May. 09	RE
Japan's Nikkei hits more than one-month high on optimism around trade talks	May. 08	RE
Ajinomoto Co., Inc. announces an Equity Buyback for 50,000,000 shares, representing 5.03% for ¥100,000 million.	May. 08	CI
Ajinomoto Co Inc - Notice Concerning Transfer Of Non-Current Assets	May. 08	RE
Ajinomoto Co Inc - To Buy Back Up To 5.03% Of Shares Worth 100 Billion Yen	May. 08	RE
Ajinomoto Co., Inc. Reports Earnings Results for the Full Year Ended March 31, 2025	May. 08	CI
Ajinomoto Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026	May. 08	CI
Ajinomoto Co., Inc. authorizes a Buyback Plan.	May. 07	CI
PCI Pharma Services completed the acquisition of Ajinomoto Althea, Inc. from Ajinomoto Co., Inc..	May. 01	CI
PCI Pharma Services signed a share transfer agreement to acquire Ajinomoto Althea, Inc. from Ajinomoto Co., Inc. for approximately $20 million.	Apr. 23	CI
Ajinomoto Co., Inc. - Analyst/Investor Day	Apr. 03
Ajinomoto (Malaysia) Announces Resignation Of Noriko Fujimoto As Executive Director	Mar. 28	RE
Ajinomoto (Malaysia) Appoints Daisaku Wadami As Executive Managing Director	Mar. 28	RE
Ajinomoto (Malaysia) Says Resignation Of Riichiro Osawa As Executive Managing Director	Mar. 28	RE
Ajinomoto Berhad Announces Resignation of Riichiro Osawa as Executive Managing Director, Effective March 31,2025	Mar. 28	CI
Ajinomoto Berhad Announces Appointment of Daisaku Wadami as Executive Managing Director/Chief Executive Officer, Effective April 01, 2025	Mar. 28	CI
Ajinomoto To Invest Over 25 Billion Yen To Boost Production Of Semiconductor Materials, President Says In Nikkei Interview	Mar. 28	RE
Enhanced Medical Nutrition Inc. announced that it has received funding from Ajinomoto Co., Inc.	Mar. 23	CI
Ajinomoto Co., Inc., Q3 2025 Earnings Call, Feb 03, 2025	Feb. 03

Chart Ajinomoto Co., Inc.

Duration

Period

2802: Dynamic Chart

Company Profile

Ajinomoto Co Inc is a Japan-based company mainly engaged in the food business. The Company operates in three business segments. Seasonings & Foods segment is engaged in the provision of seasonings, nutritional and processed foods, and solutions & ingredients. The Frozen Foods segment is engaged in the provision of frozen foods. The Health Care and Other segment is engaged in the provision of pharmaceutical- and food-use amino acids, biopharmaceutical services, functional materials, and other products and services.

Employees

34,860

Sector

Food Processing

Calendar

Jun. 19 - Annual General Meeting

More about the company